Department of Surgery, School of Medicine and Dentistry and North Queensland Centre for Cancer Research, James Cook University, Townsville, Queensland, Australia.
Dis Colon Rectum. 2011 May;54(5):535-44. doi: 10.1007/DCR.0b013e3182083d9d.
Limited information is available on predictors of postoperative mortality, morbidity, and long-term survival in patients with stage IV colorectal cancer.
This study aimed to identify independent predictors of postoperative mortality and morbidity as well as independent predictors of long-term survival.
This study was planned as a retrospective single-institution review.
This study took place at the Department of Surgery, The Royal Brisbane and Women's Hospital, Australia, between 1984 and 2004.
Prospectively collected data were extracted from the records of 1867 patients undergoing treatment for colorectal cancer. The outcomes for 379 patients undergoing surgical resection of their primary colon or rectal tumor in the presence of unresectable synchronous metastases were analyzed.
Independent predictive factors for postoperative mortality and morbidity as well as long-term survival were assessed by use of logistic regression and Cox regression analysis.
Thirty-five (9.2%) patients died in the postoperative period and morbidity was 48.3%. Median survival was 11 months. Thirty-day postoperative mortality was independently associated with medical complications (P < .001), emergency operations (P = .001), female sex (P = .002), and age (≥ 70; P = .007) on regression analysis. Elderly (≥ 70) patients with either advanced local disease or extrahepatic metastases were at a particularly high risk. Preoperative predictors of surgical morbidity included male sex (P = .028) and advanced local disease (P = .036). Preoperative predictors of medical complications included repeat operations (P < .001), elevated urea levels (P = .017), and emergency operations (P = .003). Independent factors associated with poor overall survival included medical complications (P < .001), nodal stage (N2) (P = .004), poor tumor differentiation (P = .006), and apical lymph node involvement (P = .042). A subgroup of patients with advanced nodal disease (N2) and a poor tumor differentiation had a significantly poorer prognosis.
This study was limited by its retrospective nature.
Elderly patients with advanced local disease or extrahepatic metastases are at high risk of 30-day postoperative mortality. Significant nodal disease and poor tumor differentiation are important predictors of long-term survival.
关于 IV 期结直肠癌患者术后死亡率、发病率和长期生存率的预测因素,信息有限。
本研究旨在确定术后死亡率和发病率的独立预测因素,以及长期生存率的独立预测因素。
本研究计划为回顾性单机构研究。
本研究于 1984 年至 2004 年在澳大利亚皇家布里斯班妇女医院外科进行。
从接受结直肠癌治疗的 1867 名患者的记录中提取了前瞻性收集的数据。分析了 379 名接受原发结肠或直肠肿瘤手术切除同时存在不可切除同步转移患者的结局。
使用逻辑回归和 Cox 回归分析评估术后死亡率和发病率以及长期生存率的独立预测因素。
35 例(9.2%)患者术后死亡,发病率为 48.3%。中位生存期为 11 个月。30 天术后死亡率与医疗并发症(P <.001)、急诊手术(P =.001)、女性(P =.002)和年龄(≥70 岁;P =.007)独立相关。老年(≥70 岁)患者伴有晚期局部疾病或肝外转移,风险尤其高。手术发病率的术前预测因素包括男性(P =.028)和晚期局部疾病(P =.036)。医疗并发症的术前预测因素包括再次手术(P <.001)、尿素水平升高(P =.017)和急诊手术(P =.003)。与总体生存不良相关的独立因素包括医疗并发症(P <.001)、淋巴结分期(N2)(P =.004)、肿瘤分化不良(P =.006)和顶淋巴结受累(P =.042)。一组具有晚期淋巴结疾病(N2)和肿瘤分化不良的患者预后显著较差。
本研究受到其回顾性的限制。
老年患者伴有晚期局部疾病或肝外转移,术后 30 天死亡率高。明显的淋巴结疾病和肿瘤分化不良是长期生存的重要预测因素。